MedPath

Evaluation of the association between Anti-alpha V beta 6 integrin antibody and the clinical course of ulcerative colitis after the induction therapy of Bio-JAK

Not Applicable
Conditions
ulcerative colitis
Registration Number
JPRN-UMIN000053098
Lead Sponsor
Kitasato University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1 Pregnant women, lactating women, or patients who may be pregnant 2 Patients after total colorectal resection 3 Patients with deficient serum (0W) serum at the start of treatment 4 Patients deemed inappropriate for this study by the principal investigator (in charge)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath